ClinicalTrials.Veeva

Menu

Why in Hospital After VATS Lobectomy

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Atrial Fibrillation
Infection
Postoperative Nausea and Vomiting
Pain, Postoperative
Carcinoma, Non-Small-Cell Lung
Air Leakage

Treatments

Other: Prolong in-hospital stay

Study type

Observational

Funder types

Other

Identifiers

NCT04294108
H-20014489

Details and patient eligibility

About

The study aims to identify specific or potential reasons that prolong the length of hospital stay after video-assisted thoracoscopic surgery lobectomy.

The hypothesis is that patients who are still in hospital after video-assisted thoracoscopic surgery lobectomy are associated with prolonged air leak, infection, pneumonia, atrial fibrillation or other complications or social factors.

Enrollment

160 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients referred to elective VATS lobectomy
  • Speaks and understands Danish
  • Informed consent obtained

Exclusion criteria

•Age < 18 years

Trial design

160 participants in 1 patient group

Patients underwent VATS lobectomy
Description:
All consecutive patients scheduled for video-assisted thoracoscopic surgery lobectomy.
Treatment:
Other: Prolong in-hospital stay

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems